News | March 20, 2026
LANXESS marks 40 yrs of animal disease defense 'Virkon S'
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
Marks significant milestone for breakthrough biologic to treat rare blood cancers
The trial met its primary endpoint, with patients receiving povetacicept achieving a 52.0% reduction in UPCR at Week 36
The approval comes after a systematic review of published literature
The Hydrus Microstent stands out as the first and only MIGS device backed by five-year clinical outcomes
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
Subscribe To Our Newsletter & Stay Updated
